BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24666138)

  • 1. Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domain.
    Rahman GM; Das J
    J Biomol Struct Dyn; 2015; 33(1):219-32. PubMed ID: 24666138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1 domains exposed: from diacylglycerol binding to protein-protein interactions.
    Colón-González F; Kazanietz MG
    Biochim Biophys Acta; 2006 Aug; 1761(8):827-37. PubMed ID: 16861033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
    Chen J; Deng F; Li J; Wang QJ
    Biochem J; 2008 Apr; 411(2):333-42. PubMed ID: 18076381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation mechanisms of conventional protein kinase C isoforms are determined by the ligand affinity and conformational flexibility of their C1 domains.
    Ananthanarayanan B; Stahelin RV; Digman MA; Cho W
    J Biol Chem; 2003 Nov; 278(47):46886-94. PubMed ID: 12954613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms.
    Pu Y; Peach ML; Garfield SH; Wincovitch S; Marquez VE; Blumberg PM
    J Biol Chem; 2006 Nov; 281(44):33773-88. PubMed ID: 16950780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of RasGRP binding to high-affinity PKC ligands.
    Rong SB; Enyedy IJ; Qiao L; Zhao L; Ma D; Pearce LL; Lorenzo PS; Stone JC; Blumberg PM; Wang S; Kozikowski AP
    J Med Chem; 2002 Feb; 45(4):853-60. PubMed ID: 11831896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of the interaction of the C1 domain of protein kinase C with lipid membranes by stopped-flow spectroscopy.
    Dries DR; Newton AC
    J Biol Chem; 2008 Mar; 283(12):7885-93. PubMed ID: 18187412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production.
    Dries DR; Gallegos LL; Newton AC
    J Biol Chem; 2007 Jan; 282(2):826-30. PubMed ID: 17071619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of diacylglycerol-induced membrane targeting and activation of protein kinase Cdelta.
    Stahelin RV; Digman MA; Medkova M; Ananthanarayanan B; Rafter JD; Melowic HR; Cho W
    J Biol Chem; 2004 Jul; 279(28):29501-12. PubMed ID: 15105418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling and site-directed mutagenesis studies of a phorbol ester-binding site in protein kinase C.
    Wang S; Kazanietz MG; Blumberg PM; Marquez VE; Milne GW
    J Med Chem; 1996 Jun; 39(13):2541-53. PubMed ID: 8691452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential membrane binding and diacylglycerol recognition by C1 domains of RasGRPs.
    Johnson JE; Goulding RE; Ding Z; Partovi A; Anthony KV; Beaulieu N; Tazmini G; Cornell RB; Kay RJ
    Biochem J; 2007 Sep; 406(2):223-36. PubMed ID: 17523924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the C1A and C1B domains to the membrane interaction of protein kinase C.
    Giorgione J; Hysell M; Harvey DF; Newton AC
    Biochemistry; 2003 Sep; 42(38):11194-202. PubMed ID: 14503869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
    Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM
    Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the ligand binding site of C1 domains: a molecular dynamics simulation study of the C1 domain-phorbol 13-acetate-membrane system.
    You Y; Mathukumalli K; Das J
    J Biomol Struct Dyn; 2023; 41(21):11796-11809. PubMed ID: 36602779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hydrophobic residues in the C1b domain of protein kinase C delta on ligand and phospholipid interactions.
    Wang QJ; Fang TW; Nacro K; Marquez VE; Wang S; Blumberg PM
    J Biol Chem; 2001 Jun; 276(22):19580-7. PubMed ID: 11278612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C).
    Tamamura H; Sigano DM; Lewin NE; Peach ML; Nicklaus MC; Blumberg PM; Marquez VE
    J Med Chem; 2004 Sep; 47(20):4858-64. PubMed ID: 15369389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of the receptors for the phorbol ester tumor promoters: multiple receptors with different biochemical properties.
    Kazanietz MG; Caloca MJ; Eroles P; Fujii T; García-Bermejo ML; Reilly M; Wang H
    Biochem Pharmacol; 2000 Nov; 60(10):1417-24. PubMed ID: 11020443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase Calpha contains two activator binding sites that bind phorbol esters and diacylglycerols with opposite affinities.
    Slater SJ; Ho C; Kelly MB; Larkin JD; Taddeo FJ; Yeager MD; Stubbs CD
    J Biol Chem; 1996 Mar; 271(9):4627-31. PubMed ID: 8617724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of diacyltetrol lipids as activators for the C1 domain of protein kinase C.
    Mamidi N; Gorai S; Mukherjee R; Manna D
    Mol Biosyst; 2012 Apr; 8(4):1275-85. PubMed ID: 22301880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the human targets of phorbol ester and diacylglycerol.
    Geiger M; Wrulich OA; Jenny M; Schwaiger W; Grunicke HH; Uberall F
    Curr Opin Mol Ther; 2003 Dec; 5(6):631-41. PubMed ID: 14755890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.